195 related articles for article (PubMed ID: 36251745)
41. B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.
Jaso JM; Yin CC; Lu VW; Zhao M; Abruzzo LV; You MJ; Yang Y; Luthra R; Medeiros LJ; Lu G
Mod Pathol; 2014 Mar; 27(3):382-9. PubMed ID: 24030742
[TBL] [Abstract][Full Text] [Related]
42. Identification of malignant cells in multiple myeloma bone marrow with immunoglobulin VH gene probes by fluorescent in situ hybridization and flow cytometry.
Cao J; Vescio RA; Hong CH; Kim A; Lichtenstein AK; Berenson JR
J Clin Invest; 1995 Mar; 95(3):964-72. PubMed ID: 7883997
[TBL] [Abstract][Full Text] [Related]
43. Clonal identities and multiple isotype transcripts in hematological diseases revealed by a single-strand conformation polymorphism analysis of the immunoglobulin heavy chain messenger signals.
Shiokawa S; Nishimura J; Uike N; Saburi Y; Suehiro T; Yamamoto K
Am J Hematol; 1999 Oct; 62(2):74-81. PubMed ID: 10509000
[TBL] [Abstract][Full Text] [Related]
44. Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin.
Nguyen-Khac F; Davi F; Receveur A; Maloum K; Morel V; Le Garff-Tavernier M; Ong J; Berger R; Leblond V; Merle-Béral H
Cancer Genet Cytogenet; 2005 May; 159(1):74-8. PubMed ID: 15860362
[TBL] [Abstract][Full Text] [Related]
45. Differences in immunoglobulin heavy chain gene rearrangmeent patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leaukemia at diagnosis.
Beishuizen A; Verhoeven MA; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1993 Jun; 7(6):60-3. PubMed ID: 8315958
[TBL] [Abstract][Full Text] [Related]
46. Population pharmacokinetics of lenalidomide in patients with B-cell malignancies.
Hughes JH; Phelps MA; Upton RN; Reuter SE; Gao Y; Byrd JC; Grever MR; Hofmeister CC; Marcucci G; Blum W; Blum KA; Foster DJR
Br J Clin Pharmacol; 2019 May; 85(5):924-934. PubMed ID: 30672004
[TBL] [Abstract][Full Text] [Related]
47. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
[TBL] [Abstract][Full Text] [Related]
48. Novel EZH2 mutation in a patient with secondary B-cell acute lymphocytic leukemia after deletion 5q myelodysplastic syndrome treated with lenalidomide: A case report.
Burgos S; Montalban-Bravo G; Fuente L; Jabbour EJ; Kanagal-Shamanna R; Soltysiak KA; Garcia-Manero G; Mela-Osorio MJ
Medicine (Baltimore); 2019 Jan; 98(1):e14011. PubMed ID: 30608448
[TBL] [Abstract][Full Text] [Related]
49. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.
Burmeister T; Schwartz S; Horst HA; Rieder H; Gökbuget N; Hoelzer D; Thiel E
Leukemia; 2005 Aug; 19(8):1391-8. PubMed ID: 15973450
[TBL] [Abstract][Full Text] [Related]
50. Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study.
Gillis NK; Ball M; Zhang Q; Ma Z; Zhao Y; Yoder SJ; Balasis ME; Mesa TE; Sallman DA; Lancet JE; Komrokji RS; List AF; McLeod HL; Alsina M; Baz R; Shain KH; Rollison DE; Padron E
Lancet Oncol; 2017 Jan; 18(1):112-121. PubMed ID: 27927582
[TBL] [Abstract][Full Text] [Related]
51. Clinical utility of next generation sequencing to detect IGH/IL3 rearrangements [t(5;14)(q31.1;q32.1)] in B-lymphoblastic leukemia/lymphoma.
Guenzel AJ; Smadbeck JB; Golden CL; Williamson CM; Benevides Demasi JC; Vasmatzis G; Pearce KE; Olteanu H; Xu X; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP; Peterson JF
Ann Diagn Pathol; 2021 Aug; 53():151761. PubMed ID: 33991782
[TBL] [Abstract][Full Text] [Related]
52. Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomide.
Mährle T; Akyüz N; Fuchs P; Bonzanni N; Simnica D; Germing U; Asemissen AM; Jann JC; Nolte F; Hofmann WK; Nowak D; Binder M
Haematologica; 2019 Jul; 104(7):1355-1364. PubMed ID: 30655375
[TBL] [Abstract][Full Text] [Related]
53. Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma.
Crosby J; Erzuah T; Haider M; Smith F; Ganti S; Monohan G; Elsouiedi R
J Investig Med High Impact Case Rep; 2022; 10():23247096221133204. PubMed ID: 36300378
[TBL] [Abstract][Full Text] [Related]
54. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
Chen ZY; Zhou XY; Zhang TM; Hong XN; Yin JL; Hu XC; Shi DR
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):183-8. PubMed ID: 19615255
[TBL] [Abstract][Full Text] [Related]
55. Childhood B lineage acute lymphoblastic leukemia clonality study by the polymerase chain reaction.
Scrideli CA; Simoes AL; Defavery R; Bernardes JE; Duarte MH; Tone LG
J Pediatr Hematol Oncol; 1997; 19(6):516-22. PubMed ID: 9407937
[TBL] [Abstract][Full Text] [Related]
56. Immunoglobulin heavy-chain fluorescence in situ hybridization-chromogenic in situ hybridization DNA probe split signal in the clonality assessment of lymphoproliferative processes on cytological samples.
Zeppa P; Sosa Fernandez LV; Cozzolino I; Ronga V; Genesio R; Salatiello M; Picardi M; Malapelle U; Troncone G; Vigliar E
Cancer Cytopathol; 2012 Dec; 120(6):390-400. PubMed ID: 22517675
[TBL] [Abstract][Full Text] [Related]
57. Clonality assessment and detection of clonal diversity in classic Hodgkin lymphoma by next-generation sequencing of immunoglobulin gene rearrangements.
van Bladel DAG; van den Brand M; Rijntjes J; Pamidimarri Naga S; Haacke DLCM; Luijks JACW; Hebeda KM; van Krieken JHJM; Groenen PJTA; Scheijen B
Mod Pathol; 2022 Jun; 35(6):757-766. PubMed ID: 34862451
[TBL] [Abstract][Full Text] [Related]
58. p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with lenalidomide.
Chen MH; Qi CX; Saha MN; Chang H
Am J Clin Pathol; 2012 Feb; 137(2):208-12. PubMed ID: 22261445
[TBL] [Abstract][Full Text] [Related]
59. Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia.
Steenbergen EJ; Verhagen OJ; van den Berg H; van Leeuwen EF; Behrendt H; Slater RR; von dem Borne AE; van der Schoot CE
Leukemia; 1997 Aug; 11(8):1258-65. PubMed ID: 9264379
[TBL] [Abstract][Full Text] [Related]
60. Dramatic increase in gene mutational burden after transformation of follicular lymphoma into TdT
Belman JP; Meng W; Wang HY; Li J; Strauser HT; Rosenfeld AM; Zhang Q; Prak ETL; Wasik M
Cold Spring Harb Mol Case Stud; 2020 Feb; 6(1):. PubMed ID: 31776129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
